---
$id: https://graph.org.ai/products/commodity/51171809
$type: Product
source: UNSPSC
code: "51171809"
title: "Cyclizine"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclizine

**UNSPSC Code**: 51171809
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiemetic agent with the molecular formula C18H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QRW9FCR9P2, chemically known as piperazine, 1- (diphenylmethyl)-4-methyl-, monohydrochloride but generally known as cyclizine, which bears US NIH Compound Identifier 6726. European Medicines Agency schedules Cyclizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06847MIG. The term CYCLIZINE is an International Non-Proprietary Name. World Health Organization schedules cyclizine in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclizine under HS 29335995 and SITC 51576. As of Q4 2014, CYCLIZINE remains the US FDA Preferred Term for this commodity. Cyclizine bears US NLM identifiers UMLS ID C0010547 and NCI Concept Code C65356. SMILES: N1(CCN(CC1)C)C(C1CCCCC1)C1CCCCC1.

